Forbes April 2, 2025
In this week’s edition of InnovationRx, we look at the Trump administration’s massive health agency layoffs, Palantir’s lawsuit against a YC-backed startup, Gather Health’s new primary care model, Airna’s $155 million deal, and more. To get it in your inbox, subscribe here.
Peter Marks, who oversaw the division of the FDA responsible for the approval of vaccines, gene therapies and other crucial drugs, was forced out of his role late Friday night. He wrote in his resignation letter that HHS secretary Robert F. Kennedy, Jr.. wanted “subservient confirmation of his misinformation and lies.”
The move sparked outcry from scientists, health officials and industry leaders alike. “We are deeply concerned that the loss of experienced leadership at the FDA will...
Today's Sponsors
Today's Sponsor